L. Sieminska, B. Marek, B. Kos-Kudla, D. Niedziolka, D. Kajdaniuk, M. Nowak and J. Glogowska-Szelag, “Serum Adiponectin in Women with Polycystic Ovarian Syndrome and Its Relation to Clinical, Metabolic and Endocrine Parameters,” Journal of Endocrinological Investigation, Vol. 27, No. 6, 2004, pp. 528-534.

has been cited by the following article:

• TITLE: Serum Adiponectin levels in Different Phenotypes of Polycystic Ovary Syndrome

  AUTHORS: Carolina Fux Otta, Paula Szafryk de Mereshian, Raquel Kaplan, Gabriel Santino Iraci, Silvia Ojeda, José Ochoa, Andrés Albrecht, Natalia Filipone, Marta Fiol de Cuneo

  KEYWORDS: Polycystic Ovary Syndrome; Phenotypes; Adiponectin

  JOURNAL NAME: Open Journal of Endocrine and Metabolic Diseases, Vol.2 No.4, November 30, 2012

  ABSTRACT: Objectives: to evaluate and compare serum adiponectin levels in different phenotypes of polycystic ovary syndrome (PCOS) and to investigate their correlation with endocrine and metabolic parameters. Material and methods: we studied 5 groups of patients: A (n = 20): H (hyperandrogenism) + O (oligoanovulation) + P (polycystic ovary) [classic phenotype]; B (n = 17): H + O [classic phenotype but normal ovaries]; C (n = 15): H + P [Ovulatory phenotype]; D (n = 17): O + P [Normoandrogenic phenotype]; and E (n = 16) control group. Body mass index, waist circumference, waist/hip ratio, blood pressure and hirsutism were evaluated. Serum concentrations of adiponectin, insulin, Creactive protein, SHBG, androgens and lipids were measured. Oral glucose tolerance test was performed. Results: there were no differences between the groups in terms of age and BMI. Total cholesterol, LDL-C and triglyceride levels were higher in phenotype A than in C (P P = 0.03). HOMA-IR, insulin and glucose/insulin ratio were significantly higher in phenotypes A and D vs C and E (P P P